Attached files

file filename
8-K/A - FORM 8-K/A AMENDED CURRENT REPORT - Phoenix Life Sciences International Limited.f8ka101613_8kz.htm




EXHIBIT 16.1



[f8ka101613_ex16z1001.jpg]




October 16, 2013



U.S. Securities and Exchange Commission

450 – Fifth Street N. W.

Washington, DC 20549


Re: Mokita, Inc.


Ladies and Gentlemen:


We have read the statements under item 4.01 in the Form 8-K dated October 16, 2013, of Mokita, Inc. (the Company) to be filed with the Securities and Exchange Commission and we agree with such statements therein as relate to our firm. We have no basis to, and therefore, do not agree or disagree with the other statements made by the Company in the Form 8-K.



Yours very truly,


/s/ M&K CPAS, PLLC